 |
|
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Sang Hun Song, Jong Jin Oh
J Urol Oncol. 2023;21(2):154-164. Published online 2023 Jul 31 DOI: https://doi.org/10.22465/juo.234600300015
|
|
Citations to this article as recorded by
 Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies
Sung Wook Cho, Sung Hee Lim, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park
Cancer Research and Treatment.2024; 56(3): 893. CrossRef Nomograms to Appraise The Risk of Chronic Kidney Disease After Radical Cystectomy: Shifting The Focus to Prevention
Alberto Artiles Medina, César Mínguez Ojeda, José Daniel Subiela Henríquez, Alfonso Muriel García, Álvaro Sánchez González, Marina Mata Alcaraz, Jennifer Brasero Burgos, Pablo Gajate Borau, Victoria Gómez Dos Santos, Miguel Ángel Jiménez Cidre, Francisco
Clinical Genitourinary Cancer.2024; 22(6): 102205. CrossRef This Month’s Issue of JUO
Cheol Kwak
Journal of Urologic Oncology.2023; 21(2): 95. CrossRef
|